BRIEF published on 02/02/2026 at 10:10, 6 months 7 days ago Lenzing AG Expands Stake in TreeToTextile to Lead Fiber Innovation Strategic Investment Lenzing Industrialization Sustainable Fibers TreeToTextile
PRESS RELEASE published on 02/02/2026 at 10:05, 6 months 8 days ago Lenzing AG to become majority owner of TreeToTextile AB and accelerates industrialization of new fibers Lenzing AG accelerates new fibers industrialization by becoming majority owner of TreeToTextile AB, strengthening sustainable specialty fibers position Lenzing AG Industrialization Sustainable Fibers TreeToTextile AB New Fibers
BRIEF published on 01/20/2026 at 09:10, 6 months 21 days ago Lenzing and Energie AG Extend Partnership Through 2040 Decarbonization Energy Efficiency Circular Economy Partnership Extension Emission Standards
BRIEF published on 01/20/2026 at 09:10, 6 months 21 days ago Lenzing et Energie AG prolongent leur partenariat jusqu'en 2040. Efficacité Énergétique Économie Circulaire Décarburation Extension Du Partenariat Normes D'émission
PRESS RELEASE published on 01/20/2026 at 09:05, 6 months 21 days ago Lenzing and Energie AG Umwelt Service extend RVL partnership through 2040 Lenzing AG and Energie AG Umwelt Service extend RVL partnership through 2040, ensuring long-term security of supply, increasing energy efficiency, and reducing dependence on fossil fuels Sustainability Energy Efficiency Lenzing AG Energie AG RVL Partnership
BRIEF published on 01/14/2026 at 09:14, 6 months 27 days ago Lenzing AG obtient pour la quatrième fois consécutive la note « AAA » du CDP. Lenzing AG Changement Climatique Durabilité Impact Environnemental Évaluation CDP
BRIEF published on 01/14/2026 at 09:14, 6 months 27 days ago Lenzing AG Achieves Fourth Consecutive CDP Triple “A” Rating Sustainability Environmental Impact Lenzing AG Climate Change CDP Rating
PRESS RELEASE published on 01/14/2026 at 09:09, 6 months 27 days ago Fourth CDP Triple “A” Rating reinforces Lenzing’s leadership in sustainability Lenzing AG receives fourth CDP triple 'A' rating, showcasing leadership in sustainability with top scores across climate, forests, and water categories Sustainability Lenzing AG CDP Rating Triple A
BRIEF published on 12/09/2025 at 11:15, 8 months ago Rohit Aggarwal Resigns as CEO of Lenzing AG Lenzing AG EBITDA Guidance Management Transition CEO Resignation Rohit Aggarwal
BRIEF published on 12/09/2025 at 11:15, 8 months ago Rohit Aggarwal démissionne de son poste de PDG de Lenzing AG Lenzing AG Démission Du PDG Prévisions D'EBITDA Rohit Aggarwal Transition De Gestion
Published on 08/10/2026 at 08:00, 2 hours 9 minutes ago Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Published on 08/10/2026 at 08:00, 2 hours 9 minutes ago Results of AGM and Management Update Presentation
Published on 08/07/2026 at 23:15, 2 days 10 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 11 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/10/2026 at 09:50, 19 minutes ago Photon Energy N.V. Bond 21/27 (ISIN: DE000A3KWKY4): Signs of a crisis are mounting. What can investors do? Invitation to video conferences (German/English)
Published on 08/10/2026 at 09:00, 1 hour 8 minutes ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 1 hour 8 minutes ago Original-Research: Bittium Oyj (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 1 hour 9 minutes ago Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients
Published on 08/10/2026 at 09:22, 46 minutes ago Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 09:22, 46 minutes ago Nombre total d'actions et droits de vote - juillet 2026
Published on 08/10/2026 at 07:00, 3 hours 9 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 3 hours 9 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
